MENLO PARK, Calif., July 09, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report Second Quarter of fiscal year 2026 financial results for the period ended July 3, 2026 following the close of the market on Thursday, July 30, 2026. On that day, Chief Executive Officer Dr. Catherine Corrigan, President John Pye, Executive Vice President Richard Schlenker, and Chief Financial Officer Eric Anderson, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company’s business and financial results.
Event:Exponent, Inc. Second Quarter of Fiscal Year 2026 Financial Results Conference CallDate:Thursday, July 30, 2026Time:4:30 p.m. Eastern Time / 1:30 p.m. Pacific TimeLive Call:(844) 481-2781 or (412) 317-0672 Exponent will also offer a live and archived webcast of the conference call, accessible from the Investor Relations section of the company's website, http://www.exponent.com/investors. A telephonic replay of the conference call will be available until Thursday, August 6, 2026 by dialing (855) 669-9658 or (412) 317-0088 and entering passcode 7563057#.
About Exponent
Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world.
Exponent's consultants deliver the highest value by leveraging multidisciplinary expertise and resources from across Exponent's offices in North America, Asia, and Europe. Exponent's consultants, laboratories, databases, and computing resources work seamlessly together around the globe, enabling us to produce the breakthrough insights needed to help multinational companies, startups, law firms, insurance companies, governments, and society respond to incidents and push their products and processes forward.
Exponent may be reached at (888) 656-EXPO, [email protected], or www.exponent.com.
Exponent Inc. receives a buy rating, driven by its expert consulting model in high-stakes, complex technical domains. EXPO's value proposition lies in its deep technical talent, critical for problems where failure is costly and regulatory scrutiny is high. The AI debate is a catalyst: rising complexity in physical systems should increase demand for EXPO's services, not diminish it.
Company to showcase differentiated scientific and engineering capabilities, multidisciplinary expertise, and innovation-driven growth strategy June 17, 2026 16:05 ET | Source: Exponent, Inc.
MENLO PARK, Calif., June 17, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), a leading engineering and scientific consulting firm, today announced that it will host an Investor Day at the Company’s Phoenix Test & Engineering Center on September 29, 2026, beginning at 8:30 a.m. Pacific Time.
The half-day event will feature presentations from Exponent’s executive leadership team and key market leaders, highlighting the Company’s premium service offerings, bespoke multidisciplinary solutions, and growth opportunities driven by rapid innovation, rising expectations for safety and performance, and unprecedented capital deployment into AI infrastructure.
Attendees will also tour Exponent’s Phoenix Test & Engineering Center and experience firsthand the Company’s advanced testing, failure analysis, and engineering capabilities through live demonstrations. The tour will showcase how Exponent helps clients address complex challenges at the intersection of hardware, software, AI-enabled systems, and human behavior – particularly where safety, reliability, and performance are critical.
“Our Investor Day will provide an opportunity to showcase the expertise, technical rigor, and collaborative culture that have made Exponent a trusted advisor to many of the world’s leading companies,” said Dr. Catherine Corrigan, Chief Executive Officer of Exponent. “As artificial intelligence and other emerging technologies become increasingly embedded within physical products, infrastructure, and critical systems, we see expanding opportunities for Exponent’s multidisciplinary expertise to support safety, reliability, performance, and risk mitigation. We look forward to highlighting how Exponent is uniquely positioned to support clients as innovation accelerates and system complexity grows.”
The program will highlight several key elements of Exponent’s differentiated model, including:
A uniquely multidisciplinary platform spanning more than 90 technical disciplines, enabling the firm to address highly complex, high-stakes engineering and scientific challengesDeep technical expertise and independent scientific analysis supporting mission critical decision-makingIndustry-leading capabilities in failure analysis, testing, reliability, and risk assessment for complex products and systemsExposure to long-term secular growth trends including AI and machine learning, autonomous systems, robotics, advanced consumer electronics, medical devices, energy, and data centers “Exponent’s value proposition is grounded in scientific excellence, independence, and the ability to solve problems that few organizations are equipped to address,” said Dr. John Pye, President of Exponent. “We look forward to giving investors an inside view into the expertise, infrastructure, and innovation that will continue to drive our long-term growth.”
Additional details, including registration information, will be provided closer to the event date.
About Exponent
Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world.
Exponent’s consultants deliver the highest value by leveraging multidisciplinary expertise and resources from across Exponent’s offices in North America, Asia, and Europe. Exponent’s consultants, laboratories, and integrated technical platform work seamlessly together around the globe, enabling us to produce the breakthrough insights needed to help multinational companies, startups, law firms, insurance companies, governments, and society respond to incidents and push their products and processes forward at speed.
Exponent may be reached at (888) 656-EXPO, [email protected], or www.exponent.com.
First Trust Advisors LP lifted its stake in shares of Exponent, Inc. (NASDAQ: EXPO) by 135.8% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 580,134 shares of the business services provider's stock after purchasing an additional 334,154 shares
After years of demand, the beloved color returns, powered by EXPO's new vibrant ink technology in time for the brand's 50th anniversary.
, /PRNewswire/ -- The EXPO® Yellow Dry Erase Marker, part of the Newell Brands portfolio, is back and brighter than ever. After years of requests from educators, organizers and longtime fans, the iconic shade is officially returning to the lineup following the introduction of EXPO's vibrant ink technology in 2025.
Back by Popular Demand: EXPO Reintroduces Its Iconic Yellow Dry Erase Marker
Designed for bold visibility and smooth, consistent performance, EXPO Yellow features the brand’s most vibrant ink yet. Yellow has historically been one of the most challenging colors for dry erase markers because it must be bright enough to stand out clearly on writing surfaces. With advances in EXPO's ink technology, Newell's Research and Development team enhanced the formula, so Yellow now pops on whiteboards and clear surfaces like windows.
"Yellow is a color consumers have asked us to bring back again and again," said Kris Malkoski, President, Learning & Development, Newell. "Teachers often use yellow to draw the sun and office workers gravitate to it to highlight key ideas on the board. With EXPO's vibrant ink innovation, we're excited to bring Yellow back with a bold, highly visible ink designed to stand out."
Since its discontinuation nearly two decades ago, EXPO Yellow has remained a nostalgic favorite among teachers and students who remember it as a staple of classroom color-coding systems and as a cheerful pop of color during lessons. Over the years, hundreds of consumers have asked for its return and kept the conversation alive on social media. Creators like TikToker @teachwithmx.ram, whose videos celebrate classic classroom tools, helped reignite conversation around the return of EXPO Yellow.
The return of the coveted yellow hue is powered by EXPO's new vibrant ink, introduced in 2025 across the full dry erase marker line. The improved ink delivers brighter, more saturated color designed to increase visibility on whiteboards, clear surfaces like glass, and other non-porous surfaces, making writing easier to read from a distance.
EXPO has been a partner in organizing ideas, teaching lessons, and planning everyday life for 50 years and continues to do that by listening to the people who use it most and introducing solutions to make the complicated, simple – and the simple, inspiring.
Availability
EXPO Yellow Dry Erase Markers are available now at Target and will be available at major retailers including Amazon, Walmart, Office Depot and Staples in the coming weeks. Yellow is available in both Fine Tip and Chisel Tip across various color assortments and pack sizes, including:
EXPO Dry Erase Fine Tip 12ct Assorted – Starting at $13.49 EDLP EXPO Dry Erase Chisel Tip 21ct Assorted – Starting at $21.99 EDLP EXPO Dry Erase Fine Tip 21ct Assorted – Starting at $21.99 EDLP About EXPO®
EXPO® is America's leading brand of dry and wet erase markers, trusted by teachers, professionals, parents, and creatives for bold color, clean erasing, and reliable performance. Designed to help people stay in control, EXPO products are Made for Change™ to keep ideas and plans flexible. EXPO is part of the Newell Brands global portfolio of leading brands.
About Newell Brands
Newell Brands (NASDAQ: NWL) is a leading global consumer goods company with a strong portfolio of well-known brands, including Rubbermaid, Sharpie®, Graco®, Coleman®, Rubbermaid Commercial Products®, Yankee Candle®, Paper Mate®, FoodSaver®, Dymo®, EXPO®, Elmer's®, Oster®, NUK®, Spontex® and Campingaz®. Newell Brands is focused on delighting consumers by lighting up everyday moments.
Economic strength, encouraging service activities, and the success of the work-from-home trend enable Zacks Consulting Services industry players to meet demand.
Driven by these positives, investors interested in the industry would do well to consider including stocks like Stantec Inc. (STN - Free Report) , FTI Consulting, Inc. (FCN - Free Report) and Exponent, Inc. (EXPO - Free Report) in their portfolios.
About the Industry Companies grouped under the Consulting Services category offer professional advice in management, IT, human resources, environmental regulations, logistics, marketing and real estate, serving multiple end markets. The space includes prominent names such as Accenture and Gartner. The industry focuses on channeling money and efforts toward more effective operational components, such as technology, digital transformation and data-driven decision-making. To position themselves suitably in the post-pandemic era and better utilize the opportunities that an economic recovery will bring, service providers are increasing their efforts to formulate and reassess strategic initiatives, identify sources of demand and target end markets.
What's shaping the Future of the Consulting Services Industry? Exponential Growth: This multi-billion-dollar industry has entered a trajectory of exponential expansion since the 2008 financial crisis, fueled by digital transformation and innovation-driven efficiencies. The trend has sustained steady revenues, profits and cash-flow growth, enabling most industry players to distribute stable dividends.
Economic Recovery: The sector is a major beneficiary of the broader economy and increasingly digital-driven service activities. According to the second estimate released by the Bureau of Economic Analysis, the economy remained resilient, with GDP growing 0.7% in the fourth quarter of 2025 against a 4.4% increase in the third quarter. Non-manufacturing activities remained strong, as reflected in the February Services PMI, which stayed above the 50% threshold for the 20th consecutive month.
Strong Demand Environment: The consulting services industry remains among the least disrupted by recent global uncertainties. Even in volatile conditions, organizations seek extensive guidance on safeguarding their workforce while strengthening ties with consumers and shareholders. The industry was an early pioneer of remote collaboration, now embedded in the new normal. Its work model allows players to operate efficiently, increasingly powered by AI-driven insights, digital platforms, and agile delivery frameworks.
Zacks Industry Rank Indicates Bright Prospects The Consulting Services industry, which is housed within the broader Business Services sector, currently carries a Zacks Industry Rank of #70. This rank places it in the top 29% of 243 Zacks industries.
The group’s Zacks Industry Rank, which is the average of the Zacks Rank of all the member stocks, indicates solid near-term growth prospects. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than two to one.
Before we present a few stocks that you may want to consider for your portfolio, let’s take a look at the industry’s recent stock market performance and current valuation.
Industry's Price Performance The Consulting Services industry has underperformed the S&P 500 composite and the broader sector in the past year. The industry has declined 37.4% against the S&P 500 composite’s growth of 20% and the broader sector’s 19.3% decline.
One-Year Price Performance
Industry's Current Valuation On the basis of the forward 12-month price-to-earnings (P/E), which is a commonly used multiple for valuing consulting services companies, we see that the industry is currently trading at 15.55X, above the S&P 500’s 21.39X and the sector’s 17.53X.
Over the past five years, the industry has traded as high as 31.53X and as low as 15.55X, with a median of 26.58X, as the charts below show.
Price to Forward 12 Months P/E Ratio
3 Consulting Services Stocks to Consider FTI Consulting: The company’s diversified offerings and international operations strengthen top-line growth prospects. In 2025, the company generated nearly 34% of its revenues from its international operations. The broad range of practices and services, diversified revenue streams, specialized industry expertise and global reach differentiate FTI Consulting from its competitors. This diversification enables the company to mitigate the impacts of economic cycles, crises, events, and changes in a particular practice, industry, or country.
The Zacks Consensus Estimate for the company’s 2026 EPS has increased 2.2% in the past 60 days to $9.33. FCN currently carries a Zacks Rank #2 (Buy). The stock gained 6% in the past month. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Price and Consensus: FCN
Exponent: Technological innovation continues to raise both complexity and safety expectations, and Exponent is well-positioned to capitalize on these shifts. With a strong foundation of talent and deep multidisciplinary expertise, the company delivered growth in dispute-related activities across construction, automotive and medical devices.
Proactive risk management work in the utilities sector further supported performance, offsetting softer demand in chemical regulatory engagements. Encouragingly, momentum is building in early-stage work tied to digital health, AI usability and distributed energy systems, areas with substantial growth potential. These drivers underscore Exponent’s ability to achieve sustainable growth and create long-term shareholder value.
The Zacks Consensus Estimate for the company’s 2026 EPS has increased by nearly 1% in the past 60 days to $2.27. The stock has surged 8% in the past month. EXPO currently carries a Zacks Rank #2.
Price and Consensus: EXPO
Stantec: The company provides professional services in the areas of infrastructure and facilities. It remains well-positioned for continued success, supported by industry resilience and effective internal strategies. The company benefits from strong macroeconomic and structural drivers while maintaining sharp execution on its projects, enabling margin expansion and earnings growth.
Stantec operates in a resilient sector shaped by long-term global needs, including water security, aging infrastructure, climate change response, advanced manufacturing and emerging technologies. These trends are expected to sustain strong project demand across regions.
Stantec’s consistent focus on high-quality project execution and addressing clients’ most urgent infrastructure and sustainability challenges supports steady growth. This disciplined approach continues to drive margin improvement and robust earnings performance.
The Zacks Consensus Estimate for the company’s 2025 EPS increased 6.4% in the past 60 days to $4.48. STN currently carries a Zacks Rank #2.
SG Americas Securities LLC raised its position in shares of Exponent, Inc. (NASDAQ:EXPO – Free Report) by 422.3% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 36,610 shares of the business services provider’s stock after purchasing an additional 29,600 shares during the quarter. SG Americas Securities LLC owned 0.07% of Exponent worth $2,543,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently made changes to their positions in EXPO. Hantz Financial Services Inc. boosted its holdings in shares of Exponent by 97.0% in the third quarter. Hantz Financial Services Inc. now owns 396 shares of the business services provider’s stock worth $28,000 after buying an additional 195 shares during the last quarter. Aster Capital Management DIFC Ltd purchased a new stake in Exponent during the third quarter valued at approximately $33,000. Winnow Wealth LLC purchased a new stake in Exponent during the third quarter valued at approximately $34,000. Pilgrim Partners Asia Pte Ltd bought a new position in Exponent in the third quarter worth approximately $38,000. Finally, GAMMA Investing LLC raised its position in Exponent by 50.4% in the fourth quarter. GAMMA Investing LLC now owns 576 shares of the business services provider’s stock worth $40,000 after acquiring an additional 193 shares during the period. Hedge funds and other institutional investors own 92.37% of the company’s stock.
Exponent Price Performance Shares of NASDAQ:EXPO opened at $66.56 on Friday. The company has a market capitalization of $3.28 billion, a P/E ratio of 32.00 and a beta of 0.80. Exponent, Inc. has a 1-year low of $63.25 and a 1-year high of $83.92. The firm’s 50 day simple moving average is $69.86 and its two-hundred day simple moving average is $70.47.
Exponent (NASDAQ:EXPO – Get Free Report) last announced its quarterly earnings data on Thursday, February 5th. The business services provider reported $0.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.47 by $0.02. Exponent had a net margin of 18.21% and a return on equity of 25.51%. The firm had revenue of $147.43 million during the quarter, compared to analysts’ expectations of $128.48 million. During the same period in the prior year, the company posted $0.46 earnings per share. The company’s revenue for the quarter was up 4.5% compared to the same quarter last year. On average, sell-side analysts anticipate that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.
Exponent Increases Dividend The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Stockholders of record on Friday, March 6th were given a $0.31 dividend. The ex-dividend date was Friday, March 6th. This is a positive change from Exponent’s previous quarterly dividend of $0.30. This represents a $1.24 annualized dividend and a dividend yield of 1.9%. Exponent’s dividend payout ratio (DPR) is presently 59.62%.
Insider Transactions at Exponent In related news, CEO Catherine Corrigan sold 3,920 shares of the stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $67.15, for a total transaction of $263,228.00. Following the completion of the sale, the chief executive officer owned 93,731 shares in the company, valued at approximately $6,294,036.65. This trade represents a 4.01% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, VP John Pye sold 4,000 shares of Exponent stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $75.97, for a total value of $303,880.00. Following the sale, the vice president directly owned 25,204 shares in the company, valued at $1,914,747.88. This trade represents a 13.70% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 9,583 shares of company stock valued at $687,709. Corporate insiders own 1.60% of the company’s stock.
Analysts Set New Price Targets A number of brokerages have recently issued reports on EXPO. JPMorgan Chase & Co. cut their price objective on shares of Exponent from $100.00 to $95.00 and set an “overweight” rating for the company in a research report on Thursday, March 26th. UBS Group reiterated a “neutral” rating and set a $85.00 target price on shares of Exponent in a research report on Monday, February 9th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Exponent in a report on Thursday, January 22nd. Two equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, Exponent currently has a consensus rating of “Moderate Buy” and an average price target of $90.00.
Check Out Our Latest Analysis on Exponent
Exponent Profile (Free Report)
Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.
Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.
Read More Five stocks we like better than Exponent
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEAmerican Financial Group, Inc. $AFG Shares Bought by SG Americas Securities LLC
NEXT HEADLINE »Global X Japan Co. Ltd. Has $90.55 Million Stock Holdings in NVIDIA Corporation $NVDA
MENLO PARK, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq:EXPO), a leading engineering and scientific consulting firm, today announced its appointment of John Pye to President and Eric Anderson to Chief Financial Officer, both effective May 1, 2026 and reporting to Catherine Corrigan, Chief Executive Officer; nomination of Richard Schlenker, Executive Vice President and current Chief Financial Officer to stand for election to the Board of Directors; and the appointment of Karen Richardson as Chairman of the Board upon the retirement of Paul Johnston effective as of the Annual Meeting of Stockholders to be held on June 4, 2026.
MENLO PARK, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO), today announced that it will report First Quarter of fiscal year 2026 financial results for the period ended April 3, 2026 following the close of the market on Thursday, April 30, 2026. On that day, Dr. Catherine Corrigan, Chief Executive Officer and President, and Richard Schlenker, Executive Vice President and Chief Financial Officer, will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss the Company’s business and financial results.
Event:Exponent, Inc. First Quarter of Fiscal Year 2026 Financial Results Conference CallDate:Thursday, April 30, 2026Time:4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time Live Call:(844) 481-2781 or (412) 317-0672 Exponent will also offer a live and archived webcast of the conference call, accessible from the Investor Relations section of the company's website, http://www.exponent.com/investors. A telephonic replay of the conference call will be available until Thursday, May 7, 2026 by dialing (855) 669-9658 or (412) 317-0088 and entering passcode 4146822#.
About Exponent
Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world.
Exponent's consultants deliver the highest value by leveraging multidisciplinary expertise and resources from across Exponent's offices in North America, Asia, and Europe. Exponent's consultants, laboratories, databases, and computing resources work seamlessly together around the globe, enabling us to produce the breakthrough insights needed to help multinational companies, startups, law firms, insurance companies, governments, and society respond to incidents and push their products and processes forward.
Exponent may be reached at (888) 656-EXPO, [email protected], or www.exponent.com.
Catherine Corrigan, the president and CEO of Exponent (EXPO +2.29%), reported the sale of 7,821 shares of common stock for approximately $529,000 via open-market transactions between March 16, 2026 and April 15, 2026, according to a SEC Form 4 filing.
Transaction summaryMetricValueShares sold (direct)7,821Transaction value~$529,000Post-transaction shares (direct)104,359Post-transaction value (direct ownership)~$7.13 millionTransaction value based on SEC Form 4 weighted average purchase price ($67.59); post-transaction value based on April 15, 2026 market close ($67.59).
Key questionsHow does the transaction affect Corrigan's ownership in Exponent?
The sale reduced Corrigan's direct common stock holdings by 6.97%, leaving her with 104,359 directly owned shares; she retains non-qualified stock options that may be exercised in the future.What was the nature of the transaction from a derivative perspective?
The shares sold were created through the exercise of options, with 7,821 shares immediately sold in the open market, indicating the transaction was primarily for liquidity following option vesting rather than a reduction in core investment.How does the transaction size compare to Corrigan's recent trading activity?
While Corrigan's prior trades were mostly administrative and smaller in size, this event is consistent with routine annual or periodic exercises and sales, and reflects the available share capacity after recent option-related activity.What is the context of Exponent's stock performance at the time of sale?
Exponent shares were priced at around $67.59 on the transaction dates and closed at $68.29 on April 15, 2026; the stock had declined 11.58% over the prior year, providing a neutral backdrop for option-driven insider sales.Company overviewMetricValueRevenue (TTM)$582.01 millionNet income (TTM)$106.01 millionDividend yield1.72%1-year price change-11.58%* 1-year price change calculated as of April 15, 2026.
Company snapshotExponent offers specialized consulting services across approximately 90 technical disciplines, including engineering, environmental sciences, and health sciences.The company generates revenue by providing scientific and engineering consulting services to address complex client challenges.It serves a diversified client base spanning chemical, construction, consumer products, energy, food and nutrition, government, life sciences, insurance, manufacturing, technology, transportation, and related sectors.Exponent operates as a global consulting firm with a focus on science and engineering solutions. The company’s strategy centers on delivering high-value, multidisciplinary expertise to address technically demanding problems for a broad range of industries. Exponent’s competitive edge lies in its ability to integrate advanced scientific knowledge with practical industry experience, supporting clients in risk management, regulatory compliance, and innovation.
What this transaction means for investorsCorrigan is navigating a meaningful leadership transition while still holding more than 104,000 common shares directly and retaining unexercised options, which keeps her skin in the game despite this sale. Effective May 1, John Pye steps into a newly created president role, and Eric Anderson takes over as CFO. The changes are interesting given that the stock has pulled back significantly from its 52-week high, trading around $67.85, or 15% below highs from this past year and highlighting the uncertainty around the latest executive changes and potentially even stock sales like this one.
Nevertheless, fundamentals have been holding up even if lackluster growth has disappointed investors. Fiscal year 2025 revenues before reimbursements came in at $536.8 million, up 3.5%, with net income up 5% to $106 million, or $2.07 per diluted share. Management guided for high single-digit net revenue growth in 2026, and the board raised the quarterly dividend to $0.31 per share. Ultimately, investors should watch whether management meets these goals.
Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Exponent (NASDAQ:EXPO – Get Free Report) is expected to be issuing its Q1 2026 results after the market closes on Thursday, April 30th. Analysts expect the company to announce earnings of $0.56 per share and revenue of $149.5290 million for the quarter. Interested persons can check the company’s upcoming Q1 2026 earning summary page for the latest details on the call scheduled for Thursday, April 30, 2026 at 4:30 PM ET.
Exponent (NASDAQ:EXPO – Get Free Report) last released its quarterly earnings results on Thursday, February 5th. The business services provider reported $0.49 EPS for the quarter, beating the consensus estimate of $0.47 by $0.02. Exponent had a net margin of 18.21% and a return on equity of 25.51%. The business had revenue of $147.43 million during the quarter, compared to analyst estimates of $128.48 million. During the same period in the prior year, the firm posted $0.46 earnings per share. The company’s quarterly revenue was up 4.5% on a year-over-year basis. On average, analysts expect Exponent to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.
Exponent Stock Performance NASDAQ:EXPO opened at $67.56 on Thursday. The company’s 50-day simple moving average is $68.19 and its 200-day simple moving average is $70.30. Exponent has a fifty-two week low of $63.25 and a fifty-two week high of $83.92. The stock has a market capitalization of $3.28 billion, a P/E ratio of 32.48 and a beta of 0.80.
Exponent Increases Dividend The company also recently announced a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Friday, March 6th were given a dividend of $0.31 per share. The ex-dividend date of this dividend was Friday, March 6th. This is a positive change from Exponent’s previous quarterly dividend of $0.30. This represents a $1.24 dividend on an annualized basis and a yield of 1.8%. Exponent’s dividend payout ratio is currently 59.62%.
Wall Street Analysts Forecast Growth Several equities analysts have issued reports on the stock. JPMorgan Chase & Co. cut their price target on shares of Exponent from $100.00 to $95.00 and set an “overweight” rating on the stock in a report on Thursday, March 26th. Weiss Ratings restated a “hold (c-)” rating on shares of Exponent in a research note on Thursday, January 22nd. Finally, UBS Group reiterated a “neutral” rating and issued a $85.00 price target on shares of Exponent in a research note on Monday, February 9th. Two investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, Exponent currently has an average rating of “Moderate Buy” and a consensus target price of $90.00.
Get Our Latest Research Report on EXPO
Insider Buying and Selling at Exponent In related news, VP John Pye sold 4,000 shares of the firm’s stock in a transaction on Tuesday, February 10th. The stock was sold at an average price of $75.97, for a total value of $303,880.00. Following the completion of the transaction, the vice president owned 25,204 shares in the company, valued at $1,914,747.88. This trade represents a 13.70% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Catherine Corrigan sold 3,909 shares of the business’s stock in a transaction dated Wednesday, April 15th. The shares were sold at an average price of $67.70, for a total value of $264,639.30. Following the sale, the chief executive officer owned 103,676 shares in the company, valued at approximately $7,018,865.20. The trade was a 3.63% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 15,741 shares of company stock valued at $1,095,768 over the last quarter. Insiders own 1.60% of the company’s stock.
Institutional Investors Weigh In On Exponent A number of institutional investors and hedge funds have recently modified their holdings of the company. United Services Automobile Association purchased a new position in Exponent during the 1st quarter worth approximately $270,000. Jane Street Group LLC increased its stake in shares of Exponent by 1,481.0% in the first quarter. Jane Street Group LLC now owns 127,222 shares of the business services provider’s stock worth $10,313,000 after acquiring an additional 119,175 shares during the period. Invesco Ltd. increased its stake in shares of Exponent by 3.3% in the second quarter. Invesco Ltd. now owns 554,733 shares of the business services provider’s stock worth $41,444,000 after acquiring an additional 17,930 shares during the period. First Trust Advisors LP purchased a new position in shares of Exponent during the second quarter worth $18,377,000. Finally, Walleye Capital LLC raised its holdings in shares of Exponent by 7.5% during the second quarter. Walleye Capital LLC now owns 6,623 shares of the business services provider’s stock worth $495,000 after purchasing an additional 464 shares during the last quarter. Institutional investors and hedge funds own 92.37% of the company’s stock.
About Exponent (Get Free Report)
Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.
Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.
Further Reading Five stocks we like better than Exponent
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEArrow Electronics (ARW) to Release Quarterly Earnings on Thursday
NEXT HEADLINE »Mohawk Industries (MHK) Projected to Post Earnings on Thursday
, /PRNewswire/ -- iQIYI International showcases AI-powered storytelling, Chinese anime, and VIP giveaways at the Las Vegas Convention Center on April 24–26, 2026, in partnership with premium Canadian immersive ecosystem brand, Blacklyte.
Founded in 2010, iQIYI (NASDAQ: IQ) is one of Asia's largest online entertainment platforms, and iQIYI International, launched in 2019, now serves over 100 million users across 190+ territories with a user interface and subtitles in 13 languages.
Characters from iQIYI and Blacklyte's collaborative projects, including The Great Ruler, In Search of God, and Embers. Experience the Future of AI Storytelling
At this year's LVL UP EXPO, iQIYI debuts the Peter Pau × iQIYI AI Theater, celebrating the Oscar-winning cinematographer of Crouching Tiger, Hidden Dragon. Attendees will experience three AI-generated short films that demonstrate real-world applications of AI-driven storytelling and were completed with the assistance of iQIYI's proprietary AI technology and under the guidance of human creators and artists.
Day 1 - Celestial Quest: The first work from the AI Theater delivers sci-fi action as survivors fight back. Day 2 - Shrouded Hamet: A mysterious sound-transmitting stone binds the fates of two young girls. Day 3 - A tale of the snake-catcher: A decree to hunt snakes forces a human to transform into a giant serpent. "We are thrilled to return to LVL UP EXPO for our second consecutive year," said Mr. Leo Geng, Senior Vice President of iQIYI. "Our AI Theater offers a new way to experience storytelling, and thanks to our amazing partner Blacklyte, we can offer an immersive experience unlike anywhere else at the expo."
Global Success & 2026 Lineup
Following the global success of iQIYI's original Pursuit of Jade, iQIYI continues to demonstrate its ability to deliver high-performing content in international markets. iQIYI's 2026 original lineup features over 400 new titles, strengthening its content pipeline and long-term content supply. Highlights include fantasy romance Fate Chooses You starring Ren Jialun, and the highly anticipated romance drama Overdo starring Zhang Linghe and Wang Churan.
Visit the Blacklyte Booth co-presented with iQIYI for immersive AI Theater, VIP giveaways, free merch, and a photo booth.
Event Details: April 24–26, Las Vegas Convention Center, South Hall. Booth 317
Evergreen Capital Management LLC purchased a new stake in shares of Exponent, Inc. (NASDAQ:EXPO – Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 11,081 shares of the business services provider’s stock, valued at approximately $770,000.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the business. HM Payson & Co. increased its position in shares of Exponent by 33.9% during the 3rd quarter. HM Payson & Co. now owns 589 shares of the business services provider’s stock valued at $41,000 after purchasing an additional 149 shares during the last quarter. Arizona State Retirement System increased its position in shares of Exponent by 1.1% during the 3rd quarter. Arizona State Retirement System now owns 14,984 shares of the business services provider’s stock valued at $1,041,000 after purchasing an additional 162 shares during the last quarter. GAMMA Investing LLC increased its position in shares of Exponent by 50.4% during the 4th quarter. GAMMA Investing LLC now owns 576 shares of the business services provider’s stock valued at $40,000 after purchasing an additional 193 shares during the last quarter. Hantz Financial Services Inc. increased its position in shares of Exponent by 97.0% during the 3rd quarter. Hantz Financial Services Inc. now owns 396 shares of the business services provider’s stock valued at $28,000 after purchasing an additional 195 shares during the last quarter. Finally, Orion Porfolio Solutions LLC increased its position in shares of Exponent by 2.6% during the 2nd quarter. Orion Porfolio Solutions LLC now owns 8,525 shares of the business services provider’s stock valued at $637,000 after purchasing an additional 219 shares during the last quarter. Hedge funds and other institutional investors own 92.37% of the company’s stock.
Exponent Price Performance Shares of EXPO opened at $65.88 on Friday. Exponent, Inc. has a 1 year low of $63.25 and a 1 year high of $81.95. The company has a 50 day simple moving average of $68.15 and a two-hundred day simple moving average of $70.27. The firm has a market cap of $3.20 billion, a P/E ratio of 31.67 and a beta of 0.80.
Exponent (NASDAQ:EXPO – Get Free Report) last announced its quarterly earnings data on Thursday, February 5th. The business services provider reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.47 by $0.02. Exponent had a net margin of 18.21% and a return on equity of 25.51%. The business had revenue of $147.43 million during the quarter, compared to analyst estimates of $128.48 million. During the same period last year, the firm posted $0.46 EPS. The company’s revenue was up 4.5% on a year-over-year basis. On average, sell-side analysts anticipate that Exponent, Inc. will post 2.27 earnings per share for the current year.
Exponent Increases Dividend The business also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Shareholders of record on Friday, March 6th were issued a dividend of $0.31 per share. This is an increase from Exponent’s previous quarterly dividend of $0.30. The ex-dividend date of this dividend was Friday, March 6th. This represents a $1.24 dividend on an annualized basis and a yield of 1.9%. Exponent’s payout ratio is 59.62%.
Analyst Upgrades and Downgrades EXPO has been the subject of several analyst reports. JPMorgan Chase & Co. reduced their target price on shares of Exponent from $100.00 to $95.00 and set an “overweight” rating for the company in a report on Thursday, March 26th. UBS Group reissued a “neutral” rating and issued a $85.00 target price on shares of Exponent in a report on Monday, February 9th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Exponent in a report on Tuesday. Two investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $90.00.
View Our Latest Stock Report on Exponent
Insider Buying and Selling In other Exponent news, CEO Catherine Corrigan sold 3,909 shares of the stock in a transaction that occurred on Wednesday, April 15th. The shares were sold at an average price of $67.70, for a total transaction of $264,639.30. Following the completion of the sale, the chief executive officer directly owned 103,676 shares of the company’s stock, valued at $7,018,865.20. This trade represents a 3.63% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP John Pye sold 4,000 shares of the stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $75.97, for a total transaction of $303,880.00. Following the sale, the vice president directly owned 25,204 shares of the company’s stock, valued at approximately $1,914,747.88. This trade represents a 13.70% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 15,741 shares of company stock valued at $1,095,768. Insiders own 1.60% of the company’s stock.
Exponent Company Profile (Free Report)
Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.
Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.
See Also Five stocks we like better than Exponent Want to see what other hedge funds are holding EXPO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exponent, Inc. (NASDAQ:EXPO – Free Report).
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEON Semiconductor Corporation $ON Shares Purchased by Evergreen Capital Management LLC
NEXT HEADLINE »Allison Transmission Holdings, Inc. $ALSN Shares Acquired by Caprock Group LLC
MENLO PARK, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.31 per share of common stock to be paid on June 18, 2026 to all common stockholders of record as of June 5, 2026.
Exponent has paid, and expects to continue to pay, quarterly dividends each year in March, June, September, and December. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to the final determination of Exponent’s Board of Directors.
In addition, Exponent’s Board of Directors increased the Company’s authority to repurchase shares of its common stock by $50 million. This is in addition to the $17.7 million available for repurchase as of April 3, 2026.
“Exponent’s quarterly cash dividend and increased share repurchase authorization reflects our continued commitment to returning capital to our shareholders,” commented Dr. Catherine Corrigan, President and Chief Executive Officer. “Supported by strong profitability and the strength of our balance sheet, we are well positioned to continue our disciplined capital allocation strategy and drive long-term value to shareholders.”
About Exponent
Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world.
Exponent’s consultants deliver the highest value by leveraging multidisciplinary expertise and resources from across Exponent’s offices in North America, Asia, and Europe. Exponent’s consultants, laboratories, databases, and computing resources work seamlessly together around the globe, enabling us to produce the breakthrough insights needed to help multinational companies, startups, law firms, insurance companies, governments, and society respond to incidents and push their products and processes forward.
Exponent may be reached at (888) 656-EXPO, [email protected], or www.exponent.com.
Forward Looking Statements
This news release contains, and incorporates by reference, certain “forward-looking” statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended) that are based on the beliefs of the Company’s management, as well as assumptions made by and information currently available to the Company’s management. When used in this document and in the documents incorporated herein by reference, the words “intend,” “anticipate,” “believe,” “estimate,” “expect” and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in generally applicable and industry-specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading “Risk Factors” and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.
MENLO PARK, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today reported financial results for the first quarter of fiscal year 2026 ended April 3, 2026.
“Exponent delivered double-digit growth in revenues and earnings during the first quarter, reflecting the strength of our multidisciplinary portfolio and increased demand for our specialized expertise across industries,” stated Dr. Catherine Corrigan, President and Chief Executive Officer. “Growth was driven by proactive engagements, including user research studies for consumer electronics clients integrating AI into their devices, as well as risk management work for utility clients evaluating asset performance under extreme weather conditions. Reactive engagements also contributed to our growth, with increased dispute-related and failure analysis demand across construction projects, energy facilities, and medical devices.
“The integration of AI and other advanced technologies into physical products and performance-critical systems, combined with rising expectations for safety and reliability, is driving increased reliance on Exponent’s specialized expertise. At the same time, trends in energy demand, infrastructure risk, and innovation continue to support demand for our deep technical capabilities, reinforcing our essential role in helping clients navigate complex, high-stakes decisions,” Dr. Corrigan continued.
First Quarter Financial Results
Total revenues and revenues before reimbursements for the first quarter of 2026 increased 14% to $166.3 million and 10% to $151.8 million, respectively, as compared to $145.5 million and $137.4 million in the first quarter of 2025.
Net income increased to $29.6 million, or $0.59 per diluted share, in the first quarter of 2026, as compared to $26.7 million, or $0.52 per diluted share, in the same period of 2025. During the quarter, Exponent realized a negative tax impact associated with share-based awards of $0.9 million as compared to $0.5 million in the first quarter of 2025. Inclusive of the negative tax impact, Exponent's consolidated tax rate was 30.2% in the first quarter, as compared to 29.4% for the same period in 2025.
EBITDA1 increased to $43.1 million, or 28.4% of net revenues, in the first quarter of 2026, as compared to $37.5 million, or 27.3% of net revenues in the first quarter of 2025.
During the first quarter of 2026, Exponent paid $16.6 million in dividends, repurchased $78.8 million of common stock, and closed the period with $118.6 million in cash and cash equivalents.
In a separate press release today, Exponent announced its quarterly cash dividend of $0.31 to be paid on June 18, 2026, and reiterated its intent to continue to pay quarterly dividends. Additionally, Exponent’s Board of Directors approved an increase in the current stock repurchase program of $50 million. This is in addition to the $17.7 million available for repurchases as of April 3, 2026.
Business Overview
Exponent’s engineering and other scientific segment represented 85% of the Company’s revenues before reimbursements in the first quarter of 2026. Revenues before reimbursements in this segment increased 12% in the first quarter, compared to the prior year period. Growth during the quarter was driven by user research studies in consumer electronics and risk management in the utilities sector, along with reactive engagements in the energy and life sciences sectors.
Exponent’s environmental and health segment represented 15% of the Company’s revenues before reimbursements in the first quarter. Revenues before reimbursements in this segment increased 2% in the first quarter, compared to the prior year period. Growth in this segment was primarily driven by Exponent’s regulatory consulting in the chemical industry.
Business Outlook
“Exponent delivered a strong first quarter, with 5% year-over-year headcount growth, 76% utilization, and strong rate realization driving growth,” commented Richard Schlenker, Executive Vice President and Chief Financial Officer. “We are encouraged by the market opportunities and remain confident in the long-term growth trajectory of the business.”
For the second quarter of fiscal 2026 as compared to the same period one year prior, Exponent anticipates:
Revenues before reimbursements to grow in the high-single digits; and,EBITDA1 to be 27.0% to 27.8% of revenues before reimbursements. For the full fiscal year 2026 as compared to fiscal year 2025, Exponent is maintaining its guidance and anticipates:
Revenues before reimbursements to grow in the high-single digits; and,EBITDA1 to be 27.6% to 28.1% of revenues before reimbursements. “Exponent is well positioned to support the evolving needs of our clients as innovation accelerates and systems grow more complex, particularly as AI is increasingly embedded in the physical world,” Dr. Corrigan said. “These dynamics continue to drive demand for our differentiated multidisciplinary expertise, independent evaluation, and trusted insight.
“Our recent leadership evolution further strengthens our ability to capitalize on these opportunities,” Dr. Corrigan continued. John Pye brings visionary leadership and a proven track record of innovation, playing a key role in advancing our capabilities while remaining firmly grounded in the technical rigor and independence that define Exponent. Eric Anderson adds deep financial and operational expertise, along with a strong understanding of our business and strategy. Rich Schlenker will continue to serve as Executive Vice President and has been nominated for election to the Board of Directors. Supported by our exceptional talent and distinct position in the marketplace, Exponent is well positioned to build on our momentum and deliver long-term value for our clients and shareholders.”
Today's Conference Call Information
Exponent will discuss its financial results in more detail on a conference call today, Thursday, April 30, 2026, starting at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time. The audio of the conference call is available by dialing (844) 481-2781 or (412) 317-0672. A live webcast of the call will be available on the Investor Relations section of the Company's website at www.exponent.com/investors. For those unable to listen to the live webcast, a replay of the call will also be available on the Exponent website, or by dialing (855) 669-9658 or (412) 317-0088 and entering passcode 4146822#.
Use of non-GAAP Financial Measures 1
EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest income, depreciation, and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income, and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present, and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position, or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP.
Exponent has provided its outlook regarding EBITDA as a percentage of revenues before reimbursements. The Company has not reconciled this non-GAAP financial measure to the corresponding GAAP financial measure because guidance for the various reconciling items is not provided and the Company is unable to estimate with reasonable certainty the effect of these items without unreasonable effort. For example, the Company is unable to estimate with reasonable certainty the impact of equity awards on Exponent’s taxes without unreasonable effort. These items are uncertain, depend on various factors, and may have a material effect on Exponent’s results computed in accordance with GAAP. A reconciliation between the historical GAAP and non-GAAP financial measures presented in this release is provided in the financial tables at the end of this release.
About Exponent
Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world.
Exponent's consultants deliver the highest value by leveraging multidisciplinary expertise and resources from across Exponent's offices in North America, Asia, and Europe. Exponent's consultants, laboratories, databases, and computing resources work seamlessly together around the globe, enabling us to produce the breakthrough insights needed to help multinational companies, startups, law firms, insurance companies, governments, and society respond to incidents and push their products and processes forward.
Exponent may be reached at (888) 656-EXPO, [email protected], or www.exponent.com.
Forward Looking Statements
This news release contains, and incorporates by reference, certain “forward-looking” statements (as such term is defined in the Private Securities Litigation Reform Act of 1995, and the rules promulgated pursuant to the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended) that are based on the beliefs of the Company’s management, as well as assumptions made by and information currently available to the Company’s management. When used in this document and in the documents incorporated herein by reference, the words “intend,” “anticipate,” “believe,” “estimate,” “expect” and similar expressions, as they relate to the Company or its management, identify such forward-looking statements. Such statements reflect the current views of the Company or its management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance, or achievements could differ materially from those expressed in, or implied by, any such forward-looking statements. Factors that could cause or contribute to such material differences include the possibility that the demand for our services may decline as a result of changes in generally applicable and industry-specific economic conditions, the timing of engagements for our services, the effects of competitive services and pricing, the absence of backlog related to our business, our ability to attract and retain key employees, the effect of tort reform and government regulation on our business, and liabilities resulting from claims made against us. Additional risks and uncertainties are discussed in our Annual Report on Form 10-K under the heading “Risk Factors” and elsewhere in the report. The inclusion of such forward-looking information should not be regarded as a representation by the Company or any other person that the future events, plans, or expectations contemplated by the Company will be achieved. The Company undertakes no obligation to release publicly any updates or revisions to any such forward-looking statements.
Source: Exponent, Inc.
EXPONENT, INC.CONDENSED CONSOLIDATED STATEMENTS OF INCOMEFor the Quarters Ended April 3, 2026 and April 4, 2025(unaudited)(in thousands, except per share data) Quarters Ended April 3, April 4, 2026
2025
Revenues Revenues before reimbursements
$151,817 $137,437 Reimbursements
14,486 8,070 Revenues
166,303 145,507 Operating expenses Compensation and related expenses
91,409 75,903 Other operating expenses
12,825 12,095 Reimbursable expenses
14,486 8,070 General and administrative expenses
6,204 5,007 Total operating expenses
124,924 101,075 Operating income
41,379 44,432 Other income Interest income, net
1,718 2,714 Miscellaneous income (expense), net
(758) (9,386) 960 (6,672) Income before income taxes
42,339 37,760 Income taxes 12,770 11,110 Net income
$29,569 $26,650 Net income per share: Basic
$0.59 $0.52 Diluted
$0.59 $0.52 Shares used in per share computations: Basic
49,790 51,283 Diluted
50,119 51,650 EXPONENT, INC.CONDENSED CONSOLIDATED BALANCE SHEETSApril 3, 2026 and January 2, 2026(unaudited)(in thousands) April 3, January 2, 2026
2026
Assets Current assets: Cash and cash equivalents
$118,553 $221,930 Accounts receivable, net
197,336 181,507 Prepaid expenses and other assets
24,999 24,143 Total current assets
340,888 427,580 Property, equipment and leasehold improvements, net 71,875 71,981 Operating lease right-of-use asset 70,451 73,376 Goodwill 8,607 8,607 Other assets 195,560 195,975 Total assets
$687,381 $777,519 Liabilities and Stockholders' Equity Current liabilities: Accounts payable and accrued liabilities
$37,354 $30,942 Accrued payroll and employee benefits
82,561 121,302 Deferred revenues
15,568 18,868 Operating lease liability
6,715 6,890 Total current liabilities
142,198 178,002 Other liabilities 132,523 133,232 Operating lease liability 74,323 75,944 Total liabilities
349,044 387,178 Stockholders' equity: Common stock
66 66 Additional paid-in capital
386,329 369,747 Accumulated other comprehensive loss
(2,571) (2,290)Retained earnings
682,013 668,423 Treasury stock, at cost
(727,500) (645,605)Total stockholders' equity
338,337 390,341 Total liabilities & stockholders' equity
$687,381 $777,519 EXPONENT, INC. EBITDA and EBITDAS (1) For the Quarters Ended April 3, 2026 and April 4, 2025(unaudited)(in thousands) Quarters Ended April 3, April 4, 2026
2025
Net Income$29,569 $26,650 Add back (subtract): Income taxes
12,770 11,110 Interest income, net
(1,718) (2,714) Depreciation and amortization
2,515 2,492 EBITDA (1)
43,136 37,538 Stock-based compensation
9,058 8,179 EBITDAS (1)
$52,194 $45,717 (1) EBITDA is a non-GAAP financial measure defined by the Company as net income before income taxes, interest income, depreciation and amortization. EBITDAS is a non-GAAP financial measure defined by the Company as EBITDA before stock-based compensation. The Company regards EBITDA and EBITDAS as useful measures of operating performance and cash flow to complement operating income, net income and other GAAP financial performance measures. Additionally, management believes that EBITDA and EBITDAS provide meaningful comparisons of past, present and future operating results. Generally, a non-GAAP financial measure is a numerical measure of a company's performance, financial position or cash flow that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. These measures, however, should be considered in addition to, and not as a substitute or superior to, operating income, cash flows, or other measures of financial performance prepared in accordance with GAAP.
Exponent (EXPO - Free Report) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $0.52 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +5.36%. A quarter ago, it was expected that this engineering and scientific consulting company would post earnings of $0.47 per share when it actually produced earnings of $0.49, delivering a surprise of +4.26%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Exponent, which belongs to the Zacks Consulting Services industry, posted revenues of $151.82 million for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 3.40%. This compares to year-ago revenues of $137.44 million. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Exponent shares have lost about 4.7% since the beginning of the year versus the S&P 500's gain of 4.2%.
What's Next for Exponent?While Exponent has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Exponent was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.57 on $142.6 million in revenues for the coming quarter and $2.27 on $581.31 million in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Consulting Services is currently in the top 39% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
One other stock from the same industry, Hackett Group (HCKT - Free Report) , is yet to report results for the quarter ended March 2026. The results are expected to be released on May 5.
This consulting company is expected to post quarterly earnings of $0.35 per share in its upcoming report, which represents a year-over-year change of -14.6%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.
Hackett Group's revenues are expected to be $71.65 million, down 6% from the year-ago quarter.
Exponent is a market leader in scientific and engineering consulting, boasting a 13-year dividend growth streak and a fortress balance sheet. EXPO's fiscal 2026 outlook signals rising top and bottom lines, with AI-related demand driving proactive and reactive service growth. The stock trades at ~26.5x FY26E EPS, well below its 5-year average, suggesting undervaluation with a fair value estimate of $73.80 versus a ~$65 share price.
MENLO PARK, Calif., June 05, 2026 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that Chief Executive Officer Dr. Catherine Corrigan, President John Pye, Executive Vice President Richard Schlenker, and Chief Financial Officer Eric Anderson will participate in a fireside chat at the following investor conference:
Date: Tuesday, June 9, 2026Time: 12:00 p.m. Eastern Time / 9:00 a.m. Pacific Time
A webcast of the presentation will be accessible on the investor relations section of the Exponent website, http://www.exponent.com/investors. An archived replay of the webcast will be available following the live event.
About Exponent
Exponent brings together 90+ technical disciplines and 950+ consultants to help our clients navigate the increasing complexity of more than a dozen industries, connecting decades of pioneering work in failure analysis to develop solutions for a safer, healthier, more sustainable world.
Exponent's consultants deliver the highest value by leveraging multidisciplinary expertise and resources from across Exponent's offices in North America, Asia, and Europe. Exponent's consultants, laboratories, databases, and computing resources work seamlessly together around the globe, enabling us to produce the breakthrough insights needed to help multinational companies, startups, law firms, insurance companies, governments, and society respond to incidents and push their products and processes forward.
Exponent may be reached at (888) 656-EXPO, [email protected], or www.exponent.com.
